billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 16,729
- 荣誉分数
- 5,491
- 声望点数
- 373

Pfizer/BioNTech submit initial data on Covid-19 vaccine for people ages 5 to 11 to FDA, but aren’t seeking EUA yet | CNN
Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the FDA for initial review, but are not yet seeking emergency use authorization.
Last week, Pfizer released details of a Phase 2/3 trial that showed its Covid-19 vaccine was safe and generated a "robust" antibody response in children 5-11. The trial included 2,268 5- to-11-year-olds and used a two-dose regimen of the vaccine administered 21 days apart. This trial used a 10-microgram dose -- smaller than the 30-microgram dose given to those 12 and older.
圈哥功劳不小
